The Patient Registry Software Market Size was evaluated at USD 1.72 billion in 2022, and is predicted to increase at a CAGR of 11.9% from 2023 to 2030, to reach USD 4.23 billion by 2030.
Patient registry software has a database development toolbox that allows users to establish administrative and registries databases without the requirement for database design experience or computer programming skills. This patient registration software is scalable, adjustable, and flexible, help the consumer to create databases based on data gathering requirements. Patient registry software has cloud-based access to the database, as well as an offline framework that allows the user to design an application-based database that can be placed on multiple personalized computers for offline entering data, making it ideal for data collection in areas where internet connectivity is unreliable and poor.
Get more information on Patient Registry Software Market - Request Sample Report
DRIVERS
Initiatives by the government to establish patient registries
Increasing demand to enhance treatment quality and cut healthcare costs
EHRs and other eHealth advancements are turning out to be all the more broadly utilized.
As a result of the global COVID-19 outbreak, the number of patients is increasing.
Patient registry data is increasingly being used for post-marketing surveillance.
RESTRAINTS
Worries about protection and security of information
There is a scarcity of skilled and trained personnel
OPPORTUNITIES
The number of organisations that are held accountable for their actions is increasing.
Patient registration systems in the cloud are becoming more popular.
The subscription model is widely used.
CHALLENGES
Integrity and interoperability are lacking.
Unwillingness to implement advanced solutions
Insufficient knowledge
The onset of the COVID-19 pandemic has boosted demand for patient registries, which aid researchers in determining disease prognosis and physicians in determining the best treatment for COVID-19 patients. Patient registries also aid in the collection of real-world data of therapeutic interactions and offer the possibility of studying the clinical success of treatments for various patient populations.
Patients with established health conditions, such as cardiovascular disease and cancer, are more likely to experience severe COVID-19 symptoms, according to multiple research projects. Patient registries contain useful information about patient characteristics, treatment patterns, and clinical outcomes in patients who are admitted to hospitals with predefined diseases. Many government agencies have established patient registries in order to better assess the impact of COVID-19 on patients who have previously been diagnosed with various diseases. As a result, the number of patient registries for cardiovascular illnesses and cancer that have been established expressly to study the effects of COVID-19 on these patients has increased.
By Type of Registry:
The patient registration software industry is broken down into three categories: health service, disease, and product registry. The disease registry is divided into rare disease, cardiovascular, cancer, diabetes, asthma, and other categories. In 2021, the market for patient registry software was dominated by the disease registry segment. The segment is being driven by the growing need to integrate the healthcare system and reduce disease burdens. These registries are also useful for keeping track of patients in clinical trials for the development of new medications.
By Functionality
In 2021, the industry for patient registry software was dominated by population health management. A move from a Fee-for-Service (FFS) to a Value-based Payment (VBP) model has resulted from increased demand for solutions supporting value-based care delivery by stakeholders. PHM aids in the standardization of physician approaches, the improvement of clinical results, and the reduction of disease management costs, all of which contribute to the segment's continued growth.
By Deployment Model
Because of its data security, easy recovery, and ease of access, the on-premise sector had the highest revenue share in 2021. It also comes in handy for large data file transfers and system updates. These services are preferred because they provide comprehensive access to information and complete control within the premises. Due of the protection of their data and tailored service possibilities, pharmaceutical businesses and research institutions typically select on-premise solutions.
By End User
Government and third parties, hospitals and medical practices, private payers, pharma and medical device businesses, and research organisations make up the patient registry software industry. In 2019, the government and third-party segment generated the most revenue. Over the forecast period, the installation of this software by governments in both developed and developing nations to reduce illness burden is expected to fuel the growth of the patient registry software market.
By Type of Registry
Disease Registries
Health Service Registries
Product Registries
By Functionality
Health Information Exchange (HIE)
Patient Care Management
Others
By Deployment Model
Cloud
On-Premise
By End User
Government Organizations & Research Centers
Hospitals and Clinics
Others
.png)
Need any customization research on Patient Registry Software Market - Enquiry Now
The Patient Registry Software Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa, based on region. Patient registration software is expected to be dominated by the Americas. The development of digital infrastructure in healthcare, as well as well-established EHRs, can be contributed to this region's success.
Furthermore, many major market players are purchasing regional vendors in order to improve their market positions. As per the Office of the National Coordinator for Health Information Technology, over nine out of ten office-based physicians in the United States used non-certified EHR systems, with only around four out of five switching to certified systems. The use of electronic health records (EHRs) by office-based doctors has skyrocketed. Europe had a sizable part of the patient registry software market. This is due to an increase in government initiatives to develop patient registers. Asia-Pacific is supposed to be the world's quickest developing region. This is because of the public authority's various drives pointed toward diminishing the rising strain to improve the nature of care and lower medical services costs, which are supporting the extension of the patient vault programming market in the locale. Due to lack of access and healthcare affordability among the population, the Middle East and Africa patient registry software market is predicted to rise steadily over the review period. During the assessment period, increased awareness of patient registry software is likely to boost market growth.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as follows: ArborMetrix, Dacima Software, IBM Corporation, FIGmd, IQVIA Holdings, Optum, Premier, Inc., McKesson Corporation, OpenText Corporation, Syneos Health, and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 1.72 Billion |
| Market Size by 2030 | US$ 4.23 Billion |
| CAGR | CAGR of 11.9% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type of Registry (Disease Registries, Health Service Registries, Product Registries) • By Functionality (PHM, HIE, Patient Care Management, Others) • By Deployment Model (Cloud, On-Premise) • By End User (Government Organizations & Research Centers, Hospitals and Clinics, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | ArborMetrix, Dacima Software, IBM Corporation, FIGmd, IQVIA Holdings, Optum, Premier, Inc., McKesson Corporation, OpenText Corporation, Syneos Health, and other players. |
| DRIVERS | • Initiatives by the government to establish patient registries • Increasing demand to enhance treatment quality and cut healthcare costs • EHRs and other eHealth advancements are turning out to be all the more broadly utilized. |
| RESTRAINTS | • Worries about protection and security of information • There is a scarcity of skilled and trained personnel. |
Ans: The Patient Registry Software Market size was valued at US$ 1.72 Bn in 2022.
Ans: The Patient Registry Software Market is to grow at a CAGR of 11.9% over the forecast period 2023-2030.
Key drivers of the Patient Registry Software Market is Initiatives by the government to establish patient registries, increasing demand to enhance treatment quality and cut healthcare costs.
Disease Registries, Health Service Registries, and Product Registries are the sub segments of Patient Registry Software.
Patient registration software is expected to be dominated by the Americas.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Patient Registry Software Market Segmentation, By Type of Registry
8.1 Disease Registries
8.2 Health Service Registries
8.3 Product Registries
9. Patient Registry Software Market Segmentation, By Functionality
9.1 Population Health Management (PHM)
9.2 Health Information Exchange (HIE)
9.3 Patient Care Management
9.4 Others
10. Patient Registry Software Market Segmentation, By Deployment Model
10.1 Cloud
10.2 On-Premise
11. Patient Registry Software Market Segmentation, By End User
11.1 Government Organizations & Research Centers
11.2 Hospitals and Clinics
11.3 Others
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13 Company Profiles
13.1 Wipro Limited
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Cotiviti, Inc
13.3 Conduent, Inc
13.4 DXC Technology
13.5 EXL Service Holdings, Inc.
13.6 HCL Technologies Limited
13.7 IBM
13.8 OSP Labs
13.9 Optum, Inc.
13.10 SAS Institute, Inc.
14 Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15 Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Pregnancy Pillow Market was estimated at USD 628.2 million in 2022 and is poised to reach at 805.7million in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 3.16% for the forecast period of 2023-2030.
The Genome Editing Market size was estimated USD 6.4 billion in 2022 and is expected to reach USD 23.8 billion by 2030 at a CAGR of 17.9% during the forecast period of 2023-2030.
The Active Pharmaceutical Ingredient Market Size was valued at USD 237.5 billion in 2023 and is expected to reach USD 372.8 billion by 2031 and grow at a CAGR of 5.8% over the forecast period 2024-2031.
The Digital Twins in Healthcare Market, size was estimated USD 610.1 million in 2023 and is expected to reach USD 4504.73 million by 2031 at a CAGR of 25.97% during the forecast period of 2024-2031.
The Healthcare Biometrics Market Size was valued at USD 537.03 million in 2022 and is expected to reach USD 2263.3 million by 2030 and grow at a CAGR of 19.7% over the forecast period 2023-2030.
The Cosmeceutical Market size was valued USD 56.80 billion in 2022 and is expected to reach USD 114.34 billion by 2030 and grow at a CAGR of 8.9% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
